enLIGHTEN™ the Spark in Cancer: Viral Immunotherapies Mark New Frontier

Time: 10:00 am
day: Day Two


  • To create novel viral immunotherapies to modulate the tumor microenvironment by design
  • Utilizes artificial intelligence-guided methods to break down the complexity of the tumor microenvironment, identify druggable properties that correlate with clinical outcomes, and make in silico predictions for the best payload combinations for specific indications
  • Rational selection of a viral chassis from our suite of HSV-1 vectors allows enLIGHTEN™ to exploit tunable vector features and combine, in a single therapeutic, a multimodal, programmable tumor treatment